|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02627 AB&B BIO-TECH-B
Nominal 
40.900 -1.940 (-4.528%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (199,509) | (305,988) |
| Net Cash from / (used in) Investing Activities | -- | (152,673) | (506) |
| Net Cash from / (used in) Financing Activities | -- | 439,058 | 335,166 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 86,876 | 28,672 |
| Cash & Cash Equivalents at beginning of period | -- | 45,318 | 16,646 |
| Effect of Foreign Exchange Rate Changes | -- | 0 | 0 |
| Others | -- | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 132,194 | 45,318 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -121,518 |
| %Change | -22.007% |
| EPS / (LPS) | RMB -0.340 |
| NBV Per Share (¥) | RMB -- |